Verified against court and regulatory records · No upfront fees · Your information is never sold
Quick Eligibility Review
Answer one question at a time. This usually takes under 2 minutes.
Check your eligibility — free
Answer 2-3 quick questions to review your potential case.
Free · Confidential · About 2 minutes · A case specialist responds within 1 business day
Your answers are never sold or shared without your consent.
Ethicon, a Johnson & Johnson subsidiary, manufactured the most widely implanted transvaginal mesh products in the United States. Its Gynecare TVT (mid-urethral sling for SUI), Prolift (POP repair system), and Prosima devices were marketed aggressively to gynecologists and urogynecologists despite known risks of erosion, contraction, and organ perforation. Internal company documents revealed in litigation showed Ethicon knew of complication rates but continued marketing the devices without adequate warnings.
MDL 2327, the Ethicon mesh MDL before Judge Goodwin in West Virginia, became the largest single mesh MDL with over 48,000 cases at its peak. Bellwether trials produced verdicts ranging from $1.75 million to $80 million. The eventual global settlement exceeded $775 million for POP mesh claims. SUI mesh litigation under MDL 2327 continues with ongoing remands to home districts for trial.
If you were implanted with any Ethicon mesh product — including Gynecare TVT, TVT-O, TVT Secur, Abbrevo, Prolift, Prolift+M, or Prosima — and experienced complications, you may still have an active claim. Contact People's Justice for a free, confidential case evaluation.
The full investigation